Clinical Trial

A Phase II Study of NB001 for Acute Migraine Treatment

Study acronym: Channel
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to Evaluate the Efficacy and Safety of NB001 for the Acute Treatment of Migraine in Adult patients diagnosed with migraine.
Trial Details
NCT Number NCT07577050
Lead Sponsor Chinese PLA General Hospital
Collaborators: Hebei Provincial People's Hospital, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Xiamen University, Nanjing Brain Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Xiangya Hospital of Central South University, First Affiliated Hospital Xi'an Jiaotong University, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Qingdao University, First Affiliated Hospital of Chongqing Medical University, 940 Hospital of the People's Liberation Army Joint Logistic Support Force, People's Hospital of Wuhan University, The First Hospital of Jilin University, The First Affiliated Hospital of Dalian Medical University, Peking Union Medical College Hospital, Shandong Provincial Hospital, The Second Affiliated Hospital of Army Medical University, Second Xiangya Hospital of Central South University, The Second Affiliated Hospital of Air Force Military Medical University, Fujian Medical University Union Hospital, Renmin Hospital of Wuhan University, Jiangsu Province Nanjing Brain Hospital
Conditions Migraine
Enrollment 120 participants
Start Date 2026-04-20
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-11